Bodisen Biotech (LSE:BODI) Debt-to-EBITDA : 0.00 (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bodisen Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2013 was £0.00 Mil. Bodisen Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2013 was £0.00 Mil. Bodisen Biotech's annualized EBITDA for the quarter that ended in Jun. 2013 was £-3.36 Mil. Bodisen Biotech's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2013 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Bodisen Biotech's Debt-to-EBITDA or its related term are showing as below:

LSE:BODI's Debt-to-EBITDA is not ranked ^*
in the Agriculture industry.
Industry Median: 1.99
* Ranked among companies with meaningful Debt-to-EBITDA only.

Bodisen Biotech Debt-to-EBITDA Historical Data

The historical data trend for Bodisen Biotech's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Debt-to-EBITDA Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.48

-3.31

-0.10

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
Debt-to-EBITDA	Get a 7-Day Free Trial															-	-0.55	1.48	-0.03	-

Competitive Comparison of Bodisen Biotech's Debt-to-EBITDA

For the Agricultural Inputs subindustry, Bodisen Biotech's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bodisen Biotech's Debt-to-EBITDA Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Bodisen Biotech's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bodisen Biotech's Debt-to-EBITDA falls into.

Bodisen Biotech Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bodisen Biotech's Debt-to-EBITDA for the fiscal year that ended in Dec. 2012 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.883	+	0)	/	-9.031
	=	-0.10

Bodisen Biotech's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2013 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0	+	0)	/	-3.36
	=	0.00

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2013) EBITDA data.

Bodisen Biotech (LSE:BODI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Bodisen Biotech Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.